Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) traded up 9% during mid-day trading on Friday . The stock traded as high as $0.20 and last traded at $0.19. 61,565 shares were traded during mid-day trading, an increase of 446% from the average session volume of 11,272 shares. The stock had previously closed at $0.18.
Alpha Tau Medical Stock Up 9.0 %
The firm’s 50 day moving average price is $0.20 and its 200-day moving average price is $0.22.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
Featured Articles
- Five stocks we like better than Alpha Tau Medical
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Texas Roadhouse Stock Steering for New Highs This Year
- What Does Downgrade Mean in Investing?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- How to Invest in the Best Canadian Stocks
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
